Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 609-386-0 | CAS number: 37288-11-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 September 1999 - 23 November 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 23 July 1999
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- other: in vitro mammalian chromosome aberration test (migrated information)
Test material
- Test material form:
- liquid
- Details on test material:
- Physical appearance: brown liquid
Storage conditions:in a freezer in the dark or, after thawing, in a refrigerator in the dark
Constituent 1
- Specific details on test material used for the study:
- - A correction factor of 5.2 was applied to correct for the purity of the substance.
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: cultured peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: blood samples were collected by venepuncture using the Venoject multiple sample blood collecting system with a suitable size sterile vessel containing sodium heparin. The blood samples were stored at a temperature between 4 and 25°C. Within 4 hours after blood collection, lymphocyte cultures were started.
- Sex, age and number of blood donors: healthy adult males
* dose-range finding study: age 39, Average Generation Time (AGT) = 14.2 h
* first cytogenetic assay: age 20, AGT = 13.4 h
* second cytogenetic assay: age 33, AGT = 13.9 h
MEDIA USED
- Type and identity of media: F10 complete culture medium consisted of Ham's F10 medium without thymidine and hypoxanthine (Gibco), supplemented with 20% (v/v) heat-inactivated (56°C; 30 min) foetal calf serum, L-glutamine (2mM), penicillin/streptomycin (50 U/mL and 50 µg/mL, respectively), sodium bicarbonate (1.2 g/L) and 30 U/mL heparin.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9-mix induced by Aroclor 1254.
- Test concentrations with justification for top dose:
- Dose-range finding test: 100, 333, 1000, 3330 and 5000 µg/mL
Experiment 1: 1000, 3330 and 5000 µg/mL
Experiment 2: 1000, 3330 and 5000 µg/mL - Vehicle / solvent:
- - Solvent: Milli-Q water
- Justification for choice of solvent: according to OECD guideline 473.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- Without S9
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- With S9
- Details on test system and experimental conditions:
- Two independent cytogenetic assays were performed, preceeded by a dose-range finding assay.
METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 48 h
- Exposure duration experiment 1: 3 h (with and without S9)
- Exposure duration experiment 2: 24 h and 48 h (without S9) and 3 h (with S9)
- Fixation time experiment 1: 24 h
- Fixation time experiment 2: 24 h (24 hour exposure period) and 48 h (3 and 48 hour exposure period)
ENVIRONMENTAL CONDITIONS:
- Humidity (set to maintain): 80-100%
- Temperature (set to maintain): 37.0°C
SPINDLE INHIBITOR (cytogenetic assays): colchicine (0.5 µg/mL)
STAIN (for cytogenetic assays): Giemsa
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: Fixed cells were dropped onto cleaned slides, which were immersed for 24 hours in a 1:1 mixture of 96% (v/v) ethanol (Merck)/ether (Merck) and cleaned with a tissue. At least two slides were prepared per culture. Slides were allowed to dry and thereafter stained for 10 - 30 min with 5% (v/v) Giemsa (Merck) solution in tap water. Thereafter slides were rinsed in water and allowed to dry.
NUMBER OF REPLICATIONS: duplicates in two independent experiments
NUMBER OF CELLS EVALUATED: 1000
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE: 100 per culture
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- EVALUATION CRITERIA:
A test substance was considered positive (clastogenic) in the chromosome aberration test if:
a) It induced a dose-related statistically significant (Chi-square test, P <0.05) increase in the number of cells with chromosome aberrations.
b) A statistically significant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship.
A test substance was considered negative (not clastogenic) in the chromosome aberration test if:
None of the test concentrations induced a statistically significant (Chi-square test, P<0.05) increase in the number of cells with chromosome aberrations.
ACCEPTABILITY CRITERIA:
a) The number of chromosome aberrations found in the solvent control cultures should reasonably be within the laboratory historical control data range (min=0, max=5 (mean=0.8, std dev.=1.0) aberrant cells per 100 metaphases in the absence of S9-mix; gaps excluded and min=0, max=5 (mean=0.8, std dev=0.9) aberrant cells per 100 metaphases in the presence of S9-mix; gaps excluded).
b) The positive control substances should produce a statistically significant (Chi-square test, P<0.05) increase in the number of cells with chromosome aberrations.
c) A homogeneous response between the replicate cultures is observed.
Results and discussion
Test results
- Key result
- Species / strain:
- lymphocytes: human peripheral lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no
- Effects of osmolality: no
- Precipitation: no
RANGE-FINDING/SCREENING STUDIES:
- pH: 6.81 (compared to 7.24 in the solvent control)
- Osmolarity: 291 mOsm/kg (compared to 285 in the solvent control)
EXPERIMENT 1:
- Without S9: a significant increase in the number of cells with chromosome aberrations at 1000 µg/mL was observed. Since higher concentrations did not induce a statistically or biologically significant increase in the number of cells with chromosome aberrations, the number of cells with chromosome aberrations was just outside the historical solvent control data range and the background level of the solvent control was zero, the increase is not considered biologically relevant.
- With S9: no statistically or biologically significant increase in the number of cells with chromosome aberrations was observed.
EXPERIMENT 2:
- Without S9: at the 48 hour treatment a statistically significant increase in the number of cells with chromosome aberrations at 3300 µg/mL was observed (gaps excluded). Since the highest tested concentration did not induce a statistically significant increase in the number of cells with chromosome aberrations, the number of cells with chromosome aberrations did not exceed 5% of the number of cells scored and moreover the number of cells with chromosome aberrations is still within the historical solvent control data range, the increase is considered not biologically relevant. Furthermore, 100 cells of the cultures treated with 3300 µg/mL were additionally scored for chromosome aberrations to verify that this increase was irrelevant.
In the 24 hour exposure, no statistically significant increase in the number of cells with chromosme aberrations was observed.
- With S9: no statistically significant increase in the number of cells with chromosme aberrations was observed.
ACCEPTABILITY:
- Results found in the solvent control cultures were within the laboratory historical control data range.
- The positive control chemicals (MMC-C and CP) both produced statistically significant increases in the frequency of aberrant cells.
Applicant's summary and conclusion
- Conclusions:
- Based on the results of a chromosome aberration test, performed according to OECD guideline 473 and GLP principles, NPH 54 is not clastogenic in human lymphocytes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies